Annual EBITDA
-$12.28 M
-$619.80 K-5.32%
March 31, 2024
Summary
- As of February 10, 2025, AEMD annual EBITDA is -$12.28 million, with the most recent change of -$619.80 thousand (-5.32%) on March 31, 2024.
- During the last 3 years, AEMD annual EBITDA has fallen by -$4.43 million (-56.37%).
- AEMD annual EBITDA is now -818400.00% below its all-time high of -$1500.00, reached on March 31, 1997.
Performance
AEMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.82 M
-$281.50 K-11.11%
September 30, 2024
Summary
- As of February 10, 2025, AEMD quarterly EBITDA is -$2.82 million, with the most recent change of -$281.50 thousand (-11.11%) on September 30, 2024.
- Over the past year, AEMD quarterly EBITDA has increased by +$267.60 thousand (+8.68%).
- AEMD quarterly EBITDA is now -523.12% below its all-time high of $665.60 thousand, reached on December 31, 2000.
Performance
AEMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.23 M
+$267.60 K+2.33%
September 30, 2024
Summary
- As of February 10, 2025, AEMD TTM EBITDA is -$11.23 million, with the most recent change of +$267.60 thousand (+2.33%) on September 30, 2024.
- Over the past year, AEMD TTM EBITDA has increased by +$344.90 thousand (+2.98%).
- AEMD TTM EBITDA is now -6468.01% below its all-time high of $176.30 thousand, reached on December 31, 2000.
Performance
AEMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AEMD EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.3% | +8.7% | +3.0% |
3 y3 years | -56.4% | -1.6% | +13.8% |
5 y5 years | -105.7% | -1.6% | +13.8% |
AEMD EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -56.4% | at low | -17.4% | +25.1% | -27.7% | +13.8% |
5 y | 5-year | -105.7% | at low | -247.4% | +25.1% | -97.3% | +13.8% |
alltime | all time | <-9999.0% | +5.5% | -523.1% | +62.0% | -6468.0% | +31.7% |
Aethlon Medical EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.82 M(+11.1%) | -$11.23 M(-2.3%) |
Jun 2024 | - | -$2.53 M(+5.6%) | -$11.49 M(-6.4%) |
Mar 2024 | -$12.28 M(+5.3%) | -$2.40 M(-30.9%) | -$12.28 M(+0.0%) |
Dec 2023 | - | -$3.48 M(+12.7%) | -$12.28 M(+6.1%) |
Sep 2023 | - | -$3.08 M(-7.0%) | -$11.57 M(-4.4%) |
Jun 2023 | - | -$3.32 M(+38.3%) | -$12.10 M(+3.8%) |
Mar 2023 | -$11.66 M(+13.2%) | -$2.40 M(-13.5%) | -$11.66 M(-10.5%) |
Dec 2022 | - | -$2.77 M(-23.3%) | -$13.02 M(+2.0%) |
Sep 2022 | - | -$3.61 M(+25.6%) | -$12.76 M(+15.1%) |
Jun 2022 | - | -$2.88 M(-23.5%) | -$11.09 M(+7.7%) |
Mar 2022 | -$10.30 M(+31.1%) | -$3.76 M(+49.8%) | -$10.30 M(+17.1%) |
Dec 2021 | - | -$2.51 M(+29.4%) | -$8.79 M(+0.9%) |
Sep 2021 | - | -$1.94 M(-7.0%) | -$8.71 M(+2.1%) |
Jun 2021 | - | -$2.09 M(-7.4%) | -$8.54 M(+8.7%) |
Mar 2021 | -$7.85 M(+24.6%) | -$2.25 M(-7.4%) | -$7.85 M(+6.5%) |
Dec 2020 | - | -$2.43 M(+38.1%) | -$7.37 M(+28.2%) |
Sep 2020 | - | -$1.76 M(+25.7%) | -$5.75 M(+1.0%) |
Jun 2020 | - | -$1.40 M(-21.0%) | -$5.69 M(-9.7%) |
Mar 2020 | -$6.30 M(+5.5%) | -$1.77 M(+118.9%) | -$6.30 M(+4.7%) |
Dec 2019 | - | -$810.60 K(-52.4%) | -$6.02 M(-16.3%) |
Sep 2019 | - | -$1.70 M(-15.3%) | -$7.19 M(+5.3%) |
Jun 2019 | - | -$2.01 M(+34.5%) | -$6.83 M(+15.6%) |
Mar 2019 | -$5.97 M(+12.6%) | -$1.49 M(-24.7%) | -$5.91 M(+4.1%) |
Dec 2018 | - | -$1.99 M(+48.3%) | -$5.68 M(+17.1%) |
Sep 2018 | - | -$1.34 M(+22.9%) | -$4.85 M(+2.1%) |
Jun 2018 | - | -$1.09 M(-13.7%) | -$4.74 M(-10.5%) |
Mar 2018 | -$5.30 M(-24.2%) | -$1.26 M(+9.3%) | -$5.30 M(-4.3%) |
Dec 2017 | - | -$1.15 M(-6.7%) | -$5.54 M(-0.3%) |
Sep 2017 | - | -$1.24 M(-24.9%) | -$5.55 M(-15.0%) |
Jun 2017 | - | -$1.65 M(+10.0%) | -$6.53 M(-6.6%) |
Mar 2017 | -$7.00 M(+55.8%) | -$1.50 M(+27.9%) | -$7.00 M(+5.4%) |
Dec 2016 | - | -$1.17 M(-47.2%) | -$6.64 M(+0.8%) |
Sep 2016 | - | -$2.22 M(+4.9%) | -$6.58 M(+19.6%) |
Jun 2016 | - | -$2.11 M(+85.3%) | -$5.50 M(+22.5%) |
Mar 2016 | -$4.49 M(-32.2%) | -$1.14 M(+2.1%) | -$4.49 M(+7.6%) |
Dec 2015 | - | -$1.12 M(-1.7%) | -$4.17 M(-8.3%) |
Sep 2015 | - | -$1.14 M(+3.2%) | -$4.55 M(+7.6%) |
Jun 2015 | - | -$1.10 M(+33.9%) | -$4.22 M(-37.5%) |
Mar 2015 | -$6.62 M(-49.0%) | -$821.40 K(-44.9%) | -$6.76 M(-49.3%) |
Dec 2014 | - | -$1.49 M(+83.6%) | -$13.35 M(-4.7%) |
Sep 2014 | - | -$812.30 K(-77.7%) | -$14.01 M(-14.8%) |
Jun 2014 | - | -$3.64 M(-50.9%) | -$16.43 M(+26.5%) |
Mar 2014 | -$12.99 M(+235.1%) | -$7.41 M(+245.6%) | -$12.99 M(+55.4%) |
Dec 2013 | - | -$2.14 M(-33.7%) | -$8.36 M(+44.4%) |
Sep 2013 | - | -$3.24 M(+1560.0%) | -$5.79 M(+54.5%) |
Jun 2013 | - | -$195.00 K(-93.0%) | -$3.75 M(-3.4%) |
Mar 2013 | -$3.88 M(-10.8%) | -$2.78 M(-756.7%) | -$3.88 M(-12.6%) |
Dec 2012 | - | $423.20 K(-135.4%) | -$4.44 M(-13.4%) |
Sep 2012 | - | -$1.19 M(+267.0%) | -$5.12 M(+6.6%) |
Jun 2012 | - | -$325.40 K(-90.3%) | -$4.81 M(-12.8%) |
Mar 2012 | -$4.35 M | -$3.34 M(+1173.9%) | -$5.51 M(+77.6%) |
Dec 2011 | - | -$262.20 K(-70.1%) | -$3.10 M(-20.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | -$878.00 K(-14.6%) | -$3.88 M(-12.0%) |
Jun 2011 | - | -$1.03 M(+10.1%) | -$4.41 M(-2.9%) |
Mar 2011 | -$4.54 M(+60.1%) | -$933.60 K(-10.4%) | -$4.54 M(+6.6%) |
Dec 2010 | - | -$1.04 M(-25.9%) | -$4.26 M(+8.4%) |
Sep 2010 | - | -$1.41 M(+21.4%) | -$3.93 M(+18.4%) |
Jun 2010 | - | -$1.16 M(+76.8%) | -$3.32 M(+18.5%) |
Mar 2010 | -$2.84 M(-2.5%) | -$654.60 K(-8.1%) | -$2.80 M(-1.4%) |
Dec 2009 | - | -$712.50 K(-10.4%) | -$2.84 M(-5.2%) |
Sep 2009 | - | -$794.90 K(+24.4%) | -$3.00 M(+20.7%) |
Jun 2009 | - | -$638.80 K(-8.2%) | -$2.48 M(+26.6%) |
Mar 2009 | -$2.91 M(+73.5%) | -$695.80 K(-19.8%) | -$1.96 M(+52.7%) |
Dec 2008 | - | -$867.40 K(+209.0%) | -$1.28 M(+141.2%) |
Sep 2008 | - | -$280.70 K(+138.9%) | -$532.70 K(-42.7%) |
Jun 2008 | - | -$117.50 K(+515.2%) | -$928.90 K(-44.5%) |
Mar 2008 | -$1.68 M(-8.9%) | -$19.10 K(-83.4%) | -$1.68 M(-23.3%) |
Dec 2007 | - | -$115.40 K(-83.0%) | -$2.18 M(-12.2%) |
Sep 2007 | - | -$676.90 K(-21.6%) | -$2.49 M(+9.0%) |
Jun 2007 | - | -$863.80 K(+63.5%) | -$2.28 M(+24.4%) |
Mar 2007 | -$1.84 M(+4.0%) | -$528.40 K(+26.2%) | -$1.84 M(+20.1%) |
Dec 2006 | - | -$418.80 K(-11.3%) | -$1.53 M(-0.3%) |
Sep 2006 | - | -$472.00 K(+13.4%) | -$1.53 M(+0.6%) |
Jun 2006 | - | -$416.30 K(+88.6%) | -$1.52 M(-13.8%) |
Mar 2006 | -$1.77 M(-14.8%) | -$220.70 K(-47.9%) | -$1.77 M(-15.7%) |
Dec 2005 | - | -$423.40 K(-8.6%) | -$2.10 M(-4.5%) |
Sep 2005 | - | -$463.40 K(-29.7%) | -$2.19 M(-3.9%) |
Jun 2005 | - | -$659.60 K(+19.8%) | -$2.28 M(+10.1%) |
Mar 2005 | -$2.07 M(+138.9%) | -$550.40 K(+5.5%) | -$2.07 M(+13.9%) |
Dec 2004 | - | -$521.60 K(-5.6%) | -$1.82 M(+25.7%) |
Sep 2004 | - | -$552.50 K(+22.7%) | -$1.45 M(+29.2%) |
Jun 2004 | - | -$450.20 K(+51.6%) | -$1.12 M(+29.1%) |
Mar 2004 | -$868.50 K(-41.2%) | -$296.90 K(+99.5%) | -$868.50 K(-21.2%) |
Dec 2003 | - | -$148.80 K(-34.0%) | -$1.10 M(-11.0%) |
Sep 2003 | - | -$225.50 K(+14.3%) | -$1.24 M(-14.5%) |
Jun 2003 | - | -$197.30 K(-62.8%) | -$1.45 M(-5.2%) |
Mar 2003 | -$1.48 M(-28.6%) | -$530.70 K(+86.1%) | -$1.53 M(-19.1%) |
Dec 2002 | - | -$285.20 K(-34.5%) | -$1.89 M(-4.1%) |
Sep 2002 | - | -$435.40 K(+57.4%) | -$1.97 M(+2.2%) |
Jun 2002 | - | -$276.60 K(-69.0%) | -$1.93 M(-7.1%) |
Mar 2002 | -$2.07 M(+10.8%) | -$891.60 K(+144.1%) | -$2.07 M(+0.3%) |
Dec 2001 | - | -$365.20 K(-7.0%) | -$2.07 M(+99.4%) |
Sep 2001 | - | -$392.80 K(-7.3%) | -$1.04 M(-17.7%) |
Jun 2001 | - | -$423.80 K(-52.2%) | -$1.26 M(+49.7%) |
Mar 2001 | -$1.87 M(+218.2%) | -$886.20 K(-233.1%) | -$842.40 K(-577.8%) |
Dec 2000 | - | $665.60 K(-207.9%) | $176.30 K(-122.4%) |
Sep 2000 | - | -$616.60 K(>+9900.0%) | -$788.50 K(+88.3%) |
Jun 2000 | - | -$5200.00(-103.9%) | -$418.70 K(-28.6%) |
Mar 2000 | -$586.60 K(+86.9%) | $132.50 K(-144.3%) | -$586.60 K(-18.4%) |
Dec 1999 | - | -$299.20 K(+21.2%) | -$719.10 K(+71.3%) |
Sep 1999 | - | -$246.80 K(+42.6%) | -$419.90 K(+142.6%) |
Jun 1999 | - | -$173.10 K | -$173.10 K |
Mar 1999 | -$313.80 K(-27.2%) | - | - |
Mar 1998 | -$431.10 K(>+9900.0%) | - | - |
Mar 1997 | -$1500.00 | - | - |
FAQ
- What is Aethlon Medical annual EBITDA?
- What is the all time high annual EBITDA for Aethlon Medical?
- What is Aethlon Medical annual EBITDA year-on-year change?
- What is Aethlon Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Aethlon Medical?
- What is Aethlon Medical quarterly EBITDA year-on-year change?
- What is Aethlon Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Aethlon Medical?
- What is Aethlon Medical TTM EBITDA year-on-year change?
What is Aethlon Medical annual EBITDA?
The current annual EBITDA of AEMD is -$12.28 M
What is the all time high annual EBITDA for Aethlon Medical?
Aethlon Medical all-time high annual EBITDA is -$1500.00
What is Aethlon Medical annual EBITDA year-on-year change?
Over the past year, AEMD annual EBITDA has changed by -$619.80 K (-5.32%)
What is Aethlon Medical quarterly EBITDA?
The current quarterly EBITDA of AEMD is -$2.82 M
What is the all time high quarterly EBITDA for Aethlon Medical?
Aethlon Medical all-time high quarterly EBITDA is $665.60 K
What is Aethlon Medical quarterly EBITDA year-on-year change?
Over the past year, AEMD quarterly EBITDA has changed by +$267.60 K (+8.68%)
What is Aethlon Medical TTM EBITDA?
The current TTM EBITDA of AEMD is -$11.23 M
What is the all time high TTM EBITDA for Aethlon Medical?
Aethlon Medical all-time high TTM EBITDA is $176.30 K
What is Aethlon Medical TTM EBITDA year-on-year change?
Over the past year, AEMD TTM EBITDA has changed by +$344.90 K (+2.98%)